Gratia Johns-boehme, in Hagerstown, MD - Medicare Social Worker Provider

Gratia Johns-boehme, is a medicare enrolled "Social Worker - Clinical" provider in Hagerstown, Maryland. Her current practice location is 13215 Brook Lane, Hagerstown, Maryland. You can reach out to her office (for appointments etc.) via phone at (301) 733-0330.

Gratia Johns-boehme is licensed to practice in Maryland (license number 17547) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1386672202.

Contact Information

	Gratia Johns-boehme,
	13215 Brook Lane, Hagerstown, MD 21742-1514
	(301) 733-0330
	(301) 733-4038

Healthcare Provider's Profile

Full Name	Gratia Johns-boehme
Gender	Female
Speciality	Social Worker - Clinical
Location	13215 Brook Lane, Hagerstown, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1386672202
Provider Enumeration Date: 06/29/2006
Last Update Date: 03/17/2018

Medicare PECOS Information:

PECOS PAC ID: 1759384266
Enrollment ID: I20120202000590

Medical Identifiers

Medical identifiers for Gratia Johns-boehme such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1386672202	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	17547 (Maryland)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Gratia Johns-boehme allows following entities to bill medicare on her behalf.

Entity Name	Brook Lane Health Services Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1417928151 PECOS PAC ID: 9436140068 Enrollment ID: O20040521000256

News Archive

Ground-breaking discovery gives new hope to women with particular breast cancer sub-types

Women with particular sub-types of breast cancer have been given new hope, thanks to a discovery by Queensland researchers identifying a new way to kill certain types of cancer cells.

SEC widens insider trading probe

Federal investigators are examining nearly four dozen hedge funds, asset managers and other investment firms to determine whether they violated insider-trading rules after receiving a tip from a Washington research firm.

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

FRSQ, NSFC announce funds for genomic research on male infertility

The Fonds de la recherche en santé du Québec, Génome Québec and the National Natural Science Foundation of China are pleased to announce the funding of a first project as part of their joint program for research on genomics and diseases, which was launched in July 2010.

Bayer's new oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved a new oral contraceptive, Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).

Entity Name	Brook Lane Behavioral Services, Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1538647748 PECOS PAC ID: 5991055022 Enrollment ID: O20180911000549

Ground-breaking discovery gives new hope to women with particular breast cancer sub-types

Women with particular sub-types of breast cancer have been given new hope, thanks to a discovery by Queensland researchers identifying a new way to kill certain types of cancer cells.

SEC widens insider trading probe

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

FRSQ, NSFC announce funds for genomic research on male infertility

Bayer's new oral contraceptive receives FDA approval

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gratia Johns-boehme is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gratia Johns-boehme, 13121 Brook Lane, Hagerstown, MD 21742-1514 Ph: (301) 733-0330	Gratia Johns-boehme, 13215 Brook Lane, Hagerstown, MD 21742-1514 Ph: (301) 733-0330

News Archive

Ground-breaking discovery gives new hope to women with particular breast cancer sub-types

Women with particular sub-types of breast cancer have been given new hope, thanks to a discovery by Queensland researchers identifying a new way to kill certain types of cancer cells.

SEC widens insider trading probe

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

FRSQ, NSFC announce funds for genomic research on male infertility

Bayer's new oral contraceptive receives FDA approval

Social Worker in Hagerstown, MD

Annette Jeffers, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 370 Virginia Ave, Hagerstown, MD 21740 Phone: 301-733-3130
Victoria Leizer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Public Sq # 428, Hagerstown, MD 21740 Phone: 301-514-3960
Vicki S Churchey, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 18714 N Village, Hagerstown, MD 21742 Phone: 301-733-0330 Fax: 301-733-4038
Ms. Patti Kay Cooper, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11116 Medical Campus Rd, Suite 2989, Hagerstown, MD 21742 Phone: 301-766-7600 Fax: 301-766-7702
Tammy Sherrard, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1180 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-3045 Fax: 240-313-3071
Mr. Edward John Soffe, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 113 S Prospect St, Hagerstown, MD 21740 Phone: 301-573-2800
Desirae Mehaffie, LCSWC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1180 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-3045 Fax: 240-313-3071

Gratia Johns-boehme, - Medicare Clinical Social Worker in Hagerstown, MD

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Ground-breaking discovery gives new hope to women with particular breast cancer sub-types

SEC widens insider trading probe

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

FRSQ, NSFC announce funds for genomic research on male infertility

Bayer's new oral contraceptive receives FDA approval

Ground-breaking discovery gives new hope to women with particular breast cancer sub-types

SEC widens insider trading probe

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

FRSQ, NSFC announce funds for genomic research on male infertility

Bayer's new oral contraceptive receives FDA approval

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Ground-breaking discovery gives new hope to women with particular breast cancer sub-types

SEC widens insider trading probe

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

FRSQ, NSFC announce funds for genomic research on male infertility

Bayer's new oral contraceptive receives FDA approval

Social Worker in Hagerstown, MD